Laxxon Medical | WebDisclosure

Basculer en Français

11280	Companies
250617	Keywords
179241	Articles
136432	Press releases

Home
Companies
Laxxon Medical

PRESS RELEASE

published on 10/14/2024 at 16:00, 2 years ago

Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention
Laxxon Medical to showcase innovative oral GLP-1 Agonist micro-tablet at 2024 BIO Europe Convention, aiming to enhance patient compliance. Event aims to discover new partnerships

Laxxon Medical Oral GLP-1 Agonist Patient Compliance Micro-tablet BIO Europe Convention
BRIEF

published on 10/09/2024 at 20:06, 2 years ago

Laxxon Medical to Present SPID® Technology at CPHI Milan 2024

Laxxon Medical Pharmaceutical Manufacturing SPID® Technology CGMP Printing Technology CPHI Milan 2024
BRIEF

published on 10/09/2024 at 20:06, 2 years ago

Laxxon Medical présentera la technologie SPID® au CPHI Milan 2024

Laxxon Medical Fabrication Pharmaceutique Technologie SPID® CPHI Milan 2024 Technologie D'impression CGMP
PRESS RELEASE

published on 10/09/2024 at 20:01, 2 years ago

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology

Laxxon Medical SPID® Technology CGMP Printing CPHI Milan Oral Drug Delivery
BRIEF

published on 10/01/2024 at 15:05, 2 years 1 month ago

Laxxon Medical et Adare Pharma Solutions annoncent une coopération conjointe pour la production de formes posologiques orales imprimées en 3D cGMP en Europe et aux États-Unis

Production CGMP Laxxon Medical Adare Pharma Partenariat Pharmaceutique Médicaments Imprimés En 3D
BRIEF

published on 10/01/2024 at 15:05, 2 years 1 month ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

CGMP Production Laxxon Medical Pharma Partnership 3D Printed Drugs Adare Pharma
PRESS RELEASE

published on 10/01/2024 at 15:00, 2 years 1 month ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities

Drug Delivery Laxxon Medical 3D Printed Adare Pharma Solutions CGMP
BRIEF

published on 05/22/2024 at 15:10, 2 years 5 months ago

Laxxon Medical annonce le développement d'un actif GLP-1 oral non invasif

Laxxon Medical Traitement De L'obésité Agoniste Du Récepteur GLP-1 Technologie SPID® Voie 505(b)2
BRIEF

published on 05/22/2024 at 15:10, 2 years 5 months ago

Laxxon Medical Announces Development of Non-Invasive Oral GLP-1 Asset

Obesity Treatment Laxxon Medical GLP-1 Receptor Agonist SPID® Technology 505(b)2 Pathway
PRESS RELEASE

published on 05/22/2024 at 15:05, 2 years 5 months ago

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability

Obesity Treatment Laxxon Medical GLP-1 LXM.2 3D Printed

Accesswire

Published on 11/04/2026 at 23:10, 7 hours 38 minutes ago

Ur-Energy Announces Date for Third Quarter 2026 Results and Conference Call and Webcast
Published on 11/04/2026 at 23:00, 7 hours 48 minutes ago

Avino Reports Q3 2026 Financial Results
Published on 11/04/2026 at 23:00, 7 hours 48 minutes ago

Viemed Healthcare Announces Third Quarter 2026 Financial Results
Published on 11/04/2026 at 22:15, 8 hours 33 minutes ago

Zomedica Announces Record Third Quarter Revenue of $9.9 Million, Up 22% Year-Over-Year, Net Loss Reduced 48%, with $41 Million in Liquidity
Published on 11/04/2026 at 22:05, 8 hours 43 minutes ago

Stabilis Solutions Announces Third Quarter 2026 Results

View all ACCESSWIRE

EQS Group

Published on 11/05/2026 at 06:30, 18 minutes ago

HENSOLDT increases adjusted EBITDA by 33% and refines guidance for 2026 upwards
Published on 11/05/2026 at 06:30, 18 minutes ago

Formycon invites to conference call on 2026 nine-month results and announces participation in international investor conferences
Published on 11/05/2026 at 06:20, 28 minutes ago

Zhejiang Showcases Its Cultural and Tourism Appeal in Hamburg at "Come for the Stories" Event
Published on 11/05/2026 at 05:35, 1 hour 13 minutes ago

ASADOR ETXEBARRI IS NAMED NO.1 IN THE LIST OF THE 50 BEST RESTAURANTS 2026
Published on 11/05/2026 at 04:45, 2 hours 3 minutes ago

Une princesse de Bourbon rejoint PinkPrincess, marque française de soins de luxe d’inspiration royale, à l’occasion de son lancement mondial

Les Echos

Published on 11/04/2026 at 18:00, 12 hours 48 minutes ago

The Belgian State and Engie Group have agreed to extend the target date for concluding the Heads of Terms until 12 December 2026
Published on 11/04/2026 at 18:00, 12 hours 48 minutes ago

L’État belge et le groupe ENGIE ont convenu de se donner un délai supplémentaire jusqu’au 12 décembre 2026 pour la conclusion des Heads of Terms
Published on 11/04/2026 at 17:45, 13 hours 3 minutes ago

October 2026
Published on 11/04/2026 at 17:45, 13 hours 3 minutes ago

Octobre 2026
Published on 11/04/2026 at 17:44, 13 hours 4 minutes ago

Aéroports de Paris SA - Information regarding the voting rights and shares as of 31 October 2026

View all LES ECHOS COMFI WIRE